A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Genentech, Inc.
Bristol-Myers Squibb
Seagen Inc.
KaliVir Immunotherapeutics
Eastern Cooperative Oncology Group
AstraZeneca
Radiopharm Theranostics, Ltd
Eli Lilly and Company
AstraZeneca
Terremoto Biosciences Inc.
Ensem Therapeutics
Mayo Clinic
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Sichuan Enray Pharmaceutical Sciences Company
Tizona Therapeutics, Inc
The Institute of Molecular and Translational Medicine, Czech Republic
Daiichi Sankyo
Normunity AccelCo, Inc.
University of Colorado, Denver
MacroGenics
Institut Curie
Theravectys S.A.
Karolinska University Hospital
SystImmune Inc.
Daiichi Sankyo
Grey Wolf Therapeutics
Adela, Inc
Innate Pharma
Dren Bio
OncoNano Medicine, Inc.
Tanabe Pharma America, Inc.
RenJi Hospital
Therorna
DualityBio Inc.
Massive Bio, Inc.
Chongqing Precision Biotech Co., Ltd
LigaChem Biosciences, Inc.
Washington University School of Medicine
Institut Claudius Regaud
Nurix Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
The Netherlands Cancer Institute
Yuhan Corporation
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.